Abstract
Introduction
Hepatitis B virus (HBV) is a major public health problem worldwide. In untreated chronic patients, HBV infection can cause liver cirrhosis and can progress to Hepatocellular Carcinoma (HCC) (Wong et al., 2006) . In Thailand, HBV infection is the major cause of HCC: 65% of HCC patients are infected with HBV (Tangkijvanich et al., 1999) , and patients with HBV are 20 times more likely to develop HCC (Tangkijavanich et al., 2003) . More than 85% of primary liver cancers are HCC, and over 80% of these cancer patients are located in subSaharan Africa and Eastern Asia with China having the highest HCC prevalence (EI-Serag et al., 2007) . HCC is also the most common cancer and cause of death in Thai males (Srivatanakul et al., 2004) Recently, a genome-wide association study (GWAS) conducted in 5 different locations in China discovered that a single nucleotide polymorphism (SNP) known as rs17401966 was strongly associated with the development of HCC among chronic HBV patients (Zhang et al., 2010) . This SNP is located within the 24 th intron of the kinesin family member 1B (KIF1B) gene on human chromosome 1p36.22. In several types of cancers -including HCC -KIF1B has been deleted (Bagchi et al., 2008) , which indicates that this gene may have tumor suppressor potential.
In order to understand the activity of KIF1B gene, its structure has been fully investigated. The gene encodes two spliced isoforms of kinesin protein, denoted as KIF1Bα and KIF1Bβ, which play a role in organelle and vesicle transportation in many different cell types (Nangaku et al., 1994) . Both KIF1Bα and KIF1Bβ share the same first 660 residues in the N-terminal motor domain but their C-terminal cargo-binding domains are completely different (Nangaku et al., 1994; Zhao et al., 2001) . Aside from its transportation activity, KIF1Bβ has also been shown to suppress tumor in several cancers by interacting with inhibitors of the cell cycle or activators of apoptosis (Munirajan et al., 2004) .
The major allele (A) of rs17401966 has been reported to be associated with HBV-related HCC and occurs at a frequency of 71% whereas its minor allele (G) is protective against the development of HBV-related HCC and has a frequency of 29% (Zhang et al., 2010) . In contrast, two other studies involving Koreans, Japanese, Hong Kong Chinese and Saudi Arabians (Al-Qahtani et al., 2012; Sawai et al., 2012) showed that there was no significant association between rs1740966 and the development of HBV-related HCC.
Currently, it is unclear why two separate studies conducted in China showed different results. However, because of this discrepancy -and lack of data in Thais -the authors decided to investigate the genotypic distributions and allele frequencies of rs1740966 in Thai HBV patients with and without HCC. In addition, the authors assessed whether rs1740966 is associated with the development of HBV-related HCC. The information obtained from this study will help with the management of surveillance programs of HBV-related HCC patients.
Materials and Methods

Study population
HBV-infected patients from Chulalongkorn King Memorial Hospital, Thailand between January 2012 and December, 2012 were divided into two groups: case group (with HCC) and control group (without HCC). There were 202 and 197 patients in the case and control groups, respectively. All patients, regardless of group, were HBs antigen positive. HCC was diagnosed based on clinical symptoms, ultrasonogram and/or computed tomography and an alpha fetoprotein concentration of more than 400 ng/ml. Patients who had any evidence of liver mass by ultrasonography were excluded from the control group. This study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB number 534/54). Informed consent was obtained from all patients before any procedures were performed.
Sample collection
Blood samples were collected from HBV patients with and without liver cancer. For each patient, 2-3 ml of blood was collected into an EDTA tube. PBMCs were obtained by centrifugation and put in a separation medium (Wisent Inc., Quebec, Canada) . Red blood cells were removed using Red Cell Lysis Buffer (1M Tris-HCl pH 7.6, 5 M NaCl, 1 M MgCl 2 ). PBMCs were re-suspended in Phosphate Buffer Saline (PBS) at pH 7.4 and stored at -20˚C until further analysis.
DNA extraction
DNA was extracted from 100 μL of PBMC suspension from each patient. The cells were lysed with lysis buffer (proteinase-K/SDS in Tris buffer) followed by phenol/ chloroform extraction and ethanol precipitation. The pellet was dissolved in 30 μL sterile distilled water and stored at -20˚C until further analysis.
Amplification of the KIF1B gene flanking rs17401966 region
The DNA region flanking rs17401966 of the KIF1B gene was amplified by polymerase chain reaction (PCR) using specific primers. The forward primer was rs17401966_F: 5'-ATTCATCCCACTTTAGTCATTGCAAG-3' and the reverse primer was rs17401966_R: 5'-CACAACATACTATGACTTCAGCAACT-3'. The PCR reaction was composed of 0.5 µL of 10 μM forward and reverse primers (0.2 μM final concentration for each), 10µL of 2.5X PerfectTaq Plus MasterMix (5 PRIME Inc., Hamburg, Germany), 1µL of DNA sample and distilled water up to a final volume of 25 μL. The PCR reaction was performed under the following thermal conditions: initial denaturation at 95˚C for 5 minutes; followed by 35 cycles of denaturation at 94˚C for 30 seconds, annealing at 60˚C for 30 seconds and extension at 72˚C for 45 seconds; then ending with the final extension at 72˚C for 7 minutes. To assess the size of the PCR product, electrophoresis was performed on a 2% w/v agarose gel stained with ethidium bromide. The desired PCR product size of 292 base pairs was confirmed and visualized on a UV transilluminator.
DNA purification and nucleotide sequencing
The PCR products of interest were purified from the gel using the GelExtract Mini Kit (5PRIME, Hamburg,Germany) and were used as a template for nucleotide sequencing. DNA sequencing was performed by FirstBASE Laboratories Sdn Bhd (Selangor Darul Ehsan, Malaysia). Nucleotide sequences of the samples were analyzed by using Chromas Lite (Technelysium Pty Ltd) and BLAST (http://blast.ncbi.nlm.nih.gov/Blast. cgi).
Statistical analysis
The association between SNP rs17401966 and the risk of developing HCC were assessed by using binary logistic regression. Statistical significant difference was accepted when p-value was below 0.05. The odds ratio was considered if both upper and lower 95% CI did not cover 1. Statistical parameters were calculated using SPSS for Windows v13.0 (SPSS Inc., Chicago, IL).
Results
Age and sex ratio between case and control groups
In this study, there were a total of 398 HBV-infected
Allele frequencies of rs17401966 and its association to HBV-related HCC
The frequencies of the major (A) and minor (G) alleles were comparable between both groups. In the case group, 69.6% and 30.4% had major (A) and minor (G) alleles, respectively. In the control group, 70.7% and 29.3% had major (A) and minor (G) alleles, respectively (Table 3, Figure 1B ). After adjusting for variables such as age and sex in the logistic regression analysis, minor allele (G) of rs17401966 was not significantly associated with the development of HCC [odd ratio (95% CI)=0.95 (0.70-1.28) with p=0.733] (Table 3) . The sex ratio (female/male) in the case group was 44/158 whereas in control group it was 65/131 (Table 1) .
Genotypic distributions of rs17401966 and its association to HBV-related HCC
The genotypic distributions of rs174019660 between both groups were comparable (Table 2, Figure 1A ). In the case group, 49.5% (n=100), 40.1% (n=81) and 10.4% (n=21) had homozygous major genotype (AA), heterozygous minor genotype (AG) and homozygous minor genotype (GG), respectively. Similarly, in the control group, 49.5% (n=97), 42.3% (n=83) 
Discussion
There are no data on the genotypic distributions and allele frequencies of rs17401966 in Thai HBV-infected patients, and this study is the first to report such data in Thais. The genotypic distributions between both groups were comparable for the homozygous major genotype (AA), heterozygous minor genotype (AG) and homozygous minor genotype (AA). Similar results were also observed in Japanese, Korean, Hong Kong Chinese and Saudi Arabian populations (Al-Qahtani et al., 2012; Sawai et al., 2012) . The genotypic distributions of rs17401966 among different populations are summarized in Table 4 .
In this study, the frequency of homozygous major genotype (AA) was 49.5% for both groups while frequency of heterozygous minor genotype (AG) was 40.1% and 42.3% for the case and control groups, respectively, and the frequency of homozygous minor genotype (GG) was 10.4% and 8.2% for case and control groups, respectively. The distribution of rs17401966 genotypes in the Thai population was closely related to the Hong Kong Chinese population but highly different from those found in Saudi Arabians. The genotypic distributions of rs17401966 between the case and control group were significantly different in Chinese populations from Guangxi, Beijing, Jiangsu, Guandong and Shanghai (Zhang et al., 2010) . The (AA) homozygous major genotype in the case group was significantly higher than the control group, whereas the (AG) heterozygous and (GG) heterozygous minor genotypes in the case group were lower than those found in the control group. This discrepancy indicates that there are other factors aside from ethnicity that are involved in the development of HCC. It is been previously shown that factors such as age, sex, alcohol abuse, folate intake, aflatoxin B1, mutations of p53, other viral factors, viral mutation and different genotypes of HBV may be associated with HCC development (Montesano et al., 1997; Lee et al, 2007) .
In addition, based on binary logistic regression analysis, rs17401966 was not significantly associated with the development of HCC in Thai patients chronically infected with ). This finding is in agreement with results reported in Japanese, Korean, Hong Kong Chinese and Saudi Arabian populations (AI-Qahtani et al., 2012; Sawai et al., 2012) . Although the study conducted by Zhang et al. indicated otherwise, this may be due to other factors as previously mentioned.
Thus, it is likely that a combination of other factors contribute to the development of HCC. For example, age has been shown to be positively correlated with HCC. Likewise, males are 4-5 times more likely to develop HCC compared to females (Tangkijvanich et al., 1999) . However these factors cannot be controlled for, unlike alcohol and folate consumption. Alcohol abuse will increase the risk of HCC development by 2-4 folds (Fattovich et al., 2004; Morgan et al., 2004) whereas high folate intake may help reduce the risk of developing alcohol-associated HCC (Person et al., 2013) . The correlation among these factors indicates the complexity of hepato-carcinogenesis. Another factor that may affect the development of HCC is aflatoxin B1, which is a carcinogen associated with R249S mutation in the p53 tumor suppressor gene (Groopman et al., 2005) . The p53 mutation is extremely prevalent in sub-Saharan Africa and China because of high exposure to aflatoxin (Montesano et al., 1997) . Other factors that may also contribute to the development of HCC are certain genotypes and mutations of HBV. For example, HBV genotype C was positively correlated with HCC incidence. The risk of HCC development increases if patients with HBV genotype C also have a double Basal Core Promoter mutation (Yang et al., 2008) . The prevalence of HBV genotype C in Korea, Japan, Thailand and China are 100%, 82.3%, 73% and 50.99%, respectively (Tangkijvanich et al., 2005; Kim et al., 2007; Matsuura et al., 2009) while Saudi Arabians are predominantly infected with genotype D (Abdo et al., 2006) . Thus, the different viral genotypes that predominate in each country are associated with the development of HCC in patients. Therefore, not only the allele frequency is responsible for the differences in association between rs17401966 and the risk of HBV-related HCC development. The authors speculate that there must be several factors aside from rs17401966 interacting with each other to cause discrepancies among the studies. Furthermore, the difference of mean age between case and control groups may be a limitation for the comparison of genotype and allele frequency. In conclusion, SNP rs17401966 was not associated with the risk of developing HCC in Thai HBVinfected patients. This indicates that there must be other mechanisms or pathways involved in the development of HCC.
